Waterdrop Inc. to Report Third Quarter 2021 Financial Results on November 30, 2021
BEIJING, Nov. 24, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2021, before U.S. markets open on Tuesday, November 30, 2021. Waterdrop's management...
Delta Featured Its New Delta U+ Far-UVC Light Care 222(R) Series at Industrial Transformation ASIA-PACIFIC (ITAP) 2021
SINGAPORE, Nov. 24, 2021 /PRNewswire/ -- Delta Electronics Int'l (Singapore), a provider of power and thermal management solutions, featured a range of solutions at the fourth edition of the Industrial Transformation ASIA-PACIFIC (ITAP) on 22 to 24 November 2021. They include the new Delta U+ Far-UVC Light Care 222® Series, a line of UV light disinfection devices that...
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
BOSTON, Nov. 24, 2021 /PRNewswire/ -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced the completion of $40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capital, Octagon Capital, Firstred Capital, and Elikon Venture. Existing investors - TF Capital and Med-Fine Capital -...
Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region
KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" service to four countries across the Asia-Pacific region as Amgen's contract manufacturing organization (CMO). Logo: https://kyodonewsprwire.jp/prwfile/release/M106205/202111093084/_prw_PI1fl_cWK7OADe.jpg An integral factor in Amgen's business growth in Japan, Bushu Pharma...
Mannin GmbH Implements CDD Vault Informatics Platform to Facilitate Data Management and Collaboration
LEIPZIG, Germany and SAN FRANCISCO, Nov. 24, 2021 /PRNewswire/ -- Mannin GmbH, a biotechnology company specializing in the research and development for new vascular therapeutics, announced today that it has implemented CDD Vault in its Leipzig laboratories. CDD Vault, a hosted chemistry and biology research data management platform developed by Collaborative Drug Discovery, Inc....
Global COVID-19 Safety Innovator Expands Its Offerings
"Investing smartly in the safety of employees." Including, now, a US OSHA COVID-Rules-Compliant SaaS Platform Enhancement BOSTON, Nov. 24, 2021 /PRNewswire/ -- Safely2Prosperity LLC CEO John Norris, JD, MBA, announces S2P's new COVID-19 Safety Platform and Employee Dashboard for quick demonstration and immediate deployment. Together with add-ons, they give employers the world's first comprehensive...
World’s First｜Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human
SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- On November , 2021, Aopeng Medical's ALLVAS™ Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted peripheral artery intervention of iliac artery in the Department of Vascular Surgery at Shanghai Changhai Hospital. The procedure was operated by Prof. Qing-Sheng Lu and his colleagues. The endovascular intervention surgical robot, combined with...
IND Application for Phase 3 Registration Study of KN046 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer was Approved by CDE
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the IND application for phase 3 registration study (KN046-303) of the PD-L1/CTLA-4 bispecific antibody KN046 plus nab-paclitaxel/gemcitabine for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC) was approved by the Center for Drug Evaluation (CDE) of the NMPA. KN046-303 is a randomized, double-blind, multicenter phase...
Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes – MSCI China Index
SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, today announced that the Company's stock will be added to the MSCI Global Small Cap Indexes – MSCI China Index, effective as of market...
Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine
MOSCOW, Nov. 24, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved in Lao People's Democratic Republic. Thus Laos has become the 20th country to register Sputnik Light. Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component...
